Bridging the translational gap: adenosine as a modulator of neuropathic pain in preclinical models and humans

This review aims to analyse the published data on preclinical and human experimental and clinical adenosine modulation for pain management. We summarise the translatability of the adenosine pathway for further drug development and aim to reveal subgroups of pain patients that could benefit from targ...

Full description

Bibliographic Details
Main Authors: Arendt-Nielsen Lars, Klitgaard Henrik, Hansen Stine N.
Format: Article
Language:English
Published: De Gruyter 2023-12-01
Series:Scandinavian Journal of Pain
Subjects:
Online Access:https://doi.org/10.1515/sjpain-2023-0048
_version_ 1797208473463685120
author Arendt-Nielsen Lars
Klitgaard Henrik
Hansen Stine N.
author_facet Arendt-Nielsen Lars
Klitgaard Henrik
Hansen Stine N.
author_sort Arendt-Nielsen Lars
collection DOAJ
description This review aims to analyse the published data on preclinical and human experimental and clinical adenosine modulation for pain management. We summarise the translatability of the adenosine pathway for further drug development and aim to reveal subgroups of pain patients that could benefit from targeting the pathway.
first_indexed 2024-04-24T09:39:22Z
format Article
id doaj.art-fb060803b9c6427998699169292a6813
institution Directory Open Access Journal
issn 1877-8860
1877-8879
language English
last_indexed 2024-04-24T09:39:22Z
publishDate 2023-12-01
publisher De Gruyter
record_format Article
series Scandinavian Journal of Pain
spelling doaj.art-fb060803b9c6427998699169292a68132024-04-15T07:42:32ZengDe GruyterScandinavian Journal of Pain1877-88601877-88792023-12-01241e2738310.1515/sjpain-2023-0048Bridging the translational gap: adenosine as a modulator of neuropathic pain in preclinical models and humansArendt-Nielsen Lars0Klitgaard Henrik1Hansen Stine N.2Department of Health Science and Technology, Center for Neuroplasticity and Pain, CNAP, School of Medicine, Aalborg University, Gistrup, DenmarkNEUmiRNA Therapeutics, Copenhagen, DenmarkNEUmiRNA Therapeutics, Copenhagen, DenmarkThis review aims to analyse the published data on preclinical and human experimental and clinical adenosine modulation for pain management. We summarise the translatability of the adenosine pathway for further drug development and aim to reveal subgroups of pain patients that could benefit from targeting the pathway.https://doi.org/10.1515/sjpain-2023-0048adenosineneuropathic paintranslationanimal modelshuman studies
spellingShingle Arendt-Nielsen Lars
Klitgaard Henrik
Hansen Stine N.
Bridging the translational gap: adenosine as a modulator of neuropathic pain in preclinical models and humans
Scandinavian Journal of Pain
adenosine
neuropathic pain
translation
animal models
human studies
title Bridging the translational gap: adenosine as a modulator of neuropathic pain in preclinical models and humans
title_full Bridging the translational gap: adenosine as a modulator of neuropathic pain in preclinical models and humans
title_fullStr Bridging the translational gap: adenosine as a modulator of neuropathic pain in preclinical models and humans
title_full_unstemmed Bridging the translational gap: adenosine as a modulator of neuropathic pain in preclinical models and humans
title_short Bridging the translational gap: adenosine as a modulator of neuropathic pain in preclinical models and humans
title_sort bridging the translational gap adenosine as a modulator of neuropathic pain in preclinical models and humans
topic adenosine
neuropathic pain
translation
animal models
human studies
url https://doi.org/10.1515/sjpain-2023-0048
work_keys_str_mv AT arendtnielsenlars bridgingthetranslationalgapadenosineasamodulatorofneuropathicpaininpreclinicalmodelsandhumans
AT klitgaardhenrik bridgingthetranslationalgapadenosineasamodulatorofneuropathicpaininpreclinicalmodelsandhumans
AT hansenstinen bridgingthetranslationalgapadenosineasamodulatorofneuropathicpaininpreclinicalmodelsandhumans